Tuesday, July 22, 2014

The ethics of clinical trials for cancer therapy

 2014 July-August;75(4):270-273.

The ethics of clinical trials for cancer therapy.


Author information

  • 1Division of Medical Oncology, Duke Cancer Institute; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • 2Duke Cancer Institute, Durham, North Carolina, USA. jeffrey.peppercorn@dm.duke.edu.

Abstract

Cancer clinical trials are intended to evaluate novel interventions and to improve outcomes. Such research depends on the participation of patients seeking the best options for care. The design, conduct, and analysis of trials must therefore be grounded in an ethical framework that respects and protects the interests of clinical trial participants.

No comments:

Post a Comment